Search Results - "Ahn, Eugene"

Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study by Alva, Ajjai S, Mangat, Pam K, Garrett-Mayer, Elizabeth, Halabi, Susan, Hansra, Damien, Calfa, Carmen J, Khalil, Maged F, Ahn, Eugene R, Cannon, Timothy L, Crilley, Pamela, Fisher, Julie G, Haslem, Derrick S, Shrestha, Sagun, Antonelli, Kaitlyn R, Butler, Nicole L, Warren, Sasha L, Rygiel, Andrew L, Ranasinghe, Shamika, Bruinooge, Suanna S, Schilsky, Richard L

“…The TAPUR Study is a phase II basket trial that aims to identify signals of antitumor activity of commercially available targeted agents in patients with…”
Get full text

Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study by Duvivier, Herbert L, Rothe, Michael, Mangat, Pam K, Garrett-Mayer, Elizabeth, Ahn, Eugene R, Al Baghdadi, Tareq, Alva, Ajjai S, Dublis, Stephanie A, Cannon, Timothy L, Calfa, Carmen J, Li, Rui, Behl, Deepti, Chiu, Vi K, Gold, Philip J, Marr, Alissa S, Mileham, Kathryn F, Powell, Steven Francis, Rodon, Jordi, Thota, Ramya, Grantham, Gina N, Gregory, Abigail, Hinshaw, Dominique C, Halabi, Susan, Schilsky, Richard L

“…The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is a pragmatic basket trial evaluating antitumor activity of approved targeted agents in…”
Get full text

Racial Differences in Gastroenteropancreatic Neuroendocrine Tumor Treatment and Survival in the United States by Kessel, Elizabeth, Naparst, Monica, Alpert, Naomi, Diaz, Kelly, Ahn, Eugene, Wolin, Edward, Taioli, Emanuela, Kim, Michelle Kang

“…The objective of this study was to evaluate racial differences in cancer treatment and survival in gastroenteropancreatic neuroendocrine tumor (GEP-NET)…”
Get full text

Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With ERBB2 Amplification or ERBB2/3 Mutations: Results From the TAPUR Study by Gupta, Ranju, Meric-Bernstam, Funda, Rothe, Michael, Garrett-Mayer, Elizabeth, Mangat, Pam K, D'Andre, Stacy, Ahn, Eugene R, O'Lone, Raegan, Halabi, Susan, Grantham, Gina N, Schilsky, Richard L

“…The TAPUR Study is a pragmatic phase II basket trial evaluating antitumor activity of commercially available targeted agents in patients with advanced cancers…”
Get more information

Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study by Cannon, Timothy L, Rothe, Michael, Mangat, Pam K, Garrett-Mayer, Elizabeth, Chiu, Vi K, Hwang, Jimmy, Vijayvergia, Namrata, Alese, Olatunji B, Dib, Elie G, Duvivier, Herbert L, Klute, Kelsey A, Sahai, Vaibhav, Ahn, Eugene R, Bedano, Pablo, Behl, Deepti, Sinclair, Sarah, Thota, Ramya, Urba, Walter J, Yang, Eddy S, Grantham, Gina N, Hinshaw, Dominique C, Gregory, Abigail, Halabi, Susan, Schilsky, Richard L

“…Targeted Agent and Profiling Utilization Registry is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in…”
Get full text

Dual HER2-targeted approaches in HER2-positive breast cancer by Ahn, Eugene R., Vogel, Charles L.

“…Approximately 15–20% of all breast cancers are human epidermal growth factor receptor 2 (HER2) positive, with clinical studies having validated the HER2…”
Get full text

Improved Clinical Outcomes Associated With Vitamin D Supplementation During Adjuvant Chemotherapy in Patients With HER2+ Nonmetastatic Breast Cancer by Zeichner, Simon B, Koru-Sengul, Tulay, Shah, Nikesh, Liu, Qingyun, Markward, Nathan J, Montero, Alberto J, Glück, Stefan, Silva, Orlando, Ahn, Eugene R

“…Micro-Abstract Vitamin D (VD) supplementation has pleiotropic effects that extend beyond their impact on bone health, including the disruption of human…”
Get full text

Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients by Baeg, Kiwoon, Harris, Cynthia, Naparst, Monica S, Ahn, Eugene, Thapi, Sahityasri, Martin, Jacob, Rustgi, Sheila, Mhango, Grace, Wisnivesky, Juan, Kim, Michelle Kang

“…Medical centers with varying levels of expertise treat gastroenteropancreatic neuroendocrine tumors (GEP-NETs), which are relatively rare tumors. This study…”
Get full text

Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature by Zeichner, Simon B., Herna, Stuart, Mani, Aruna, Ambros, Tadeu, Montero, Alberto J., Mahtani, Reshma L., Ahn, Eugene R., Vogel, Charles L.

“…Approximately 6 % of patients with breast cancer are diagnosed with de-novo distant metastases. We set out to look at two cohorts of patients seen at breast…”
Get full text

Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study by Al Baghdadi, Tareq, Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Rich, Patricia, Ahn, Eugene R., Chai, Seungjean, Rygiel, Andrew L., Osayameh, Olufunlayo, Antonelli, Kaitlyn R., Islam, Samiha, Bruinooge, Suanna S., Schilsky, Richard L.

“…Background TAPUR is a pragmatic, phase II basket study evaluating the antitumor activity of commercially available targeted agents in patients with advanced…”
Get full text

Talazoparib in Patients With Solid Tumors With BRCA1 / 2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study by Srkalovic, Gordan, Rothe, Michael, Mangat, Pam K, Garrett-Mayer, Elizabeth, Ahn, Eugene R, Brouse, Gregory, Chan, John, Mehmi, Inderjit, Khalil, Maya, Duvivier, Herbert L, Gaba, Anu, Leuva, Harshraj, Thota, Ramya, Yost, Kathleen J, Grantham, Gina N, Gregory, Abigail, Hinshaw, Dominique C, Halabi, Susan, Schilsky, Richard L

“…The Targeted Agent and Profiling Utilization Registry Study is a phase II basket trial evaluating the antitumor activity of commercially available targeted…”
Get more information

Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study by Klute, Kelsey A, Rothe, Michael, Garrett-Mayer, Elizabeth, Mangat, Pam K, Nazemzadeh, Reza, Yost, Kathleen J, Duvivier, Herbert L, Ahn, Eugene R, Cannon, Timothy L, Alese, Olatunji B, Krauss, John C, Thota, Ramya, Calfa, Carmen J, Denlinger, Crystal S, O'Lone, Raegan, Halabi, Susan, Grantham, Gina N, Schilsky, Richard L

“…TAPUR is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancer and genomic…”
Get more information

Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study by Ahn, Eugene R, Rothe, Michael, Mangat, Pam K, Garrett-Mayer, Elizabeth, Ali-Ahmad, Hussein M, Chan, John, Maitland, Michael L, Patel, Sapna R, Reese, Zachary, Balmanoukian, Ani S, Drescher, Charles W, Li, Rui, Tsimberidou, Apostolia M, Leath, 3rd, Charles A, O'Lone, Raegan, Grantham, Gina N, Halabi, Susan, Schilsky, Richard L

“…The TAPUR Study is a pragmatic basket trial evaluating antitumor activity of commercially available targeted agents in patients with advanced cancers harboring…”
Get more information

Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study by Ganti, Apar K, Rothe, Michael, Mangat, Pam K, Garrett-Mayer, Elizabeth, Dib, Elie G, Duvivier, Herbert L, Ahn, Eugene R, Behl, Deepti, Borghaei, Hossein, Balmanoukian, Ani S, Gaba, Anu, Li, Rui, Osei-Boateng, Kwabena, Thota, Ramya, Grantham, Gina N, Gregory, Abigail, Halabi, Susan, Schilsky, Richard L

“…The Targeted Agent and Profiling Utilization Registry Study is a pragmatic basket trial evaluating antitumor activity of commercially available targeted agents…”
Get more information

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study by Calfa, Carmen J, Rothe, Michael, Mangat, Pam K, Garrett-Mayer, Elizabeth, Ahn, Eugene R, Burness, Monika L, Gogineni, Keerthi, Rohatgi, Nitin, Al Baghdadi, Tareq, Conlin, Alison, Gaba, Anu, Hamid, Omid, Krishnamurthy, Jairam, Gavini, Naga Jyothi, Gold, Philip J, Rodon, Jordi, Rueter, Jens, Thota, Ramya, Grantham, Gina N, Hinshaw, Dominique C, Gregory, Abigail, Halabi, Susan, Schilsky, Richard L

“…The Targeted Agent and Profiling Utilization Registry Study is a phase II basket trial evaluating the antitumor activity of commercially available targeted…”
Get more information

Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study by Meric-Bernstam, Funda, Rothe, Michael, Mangat, Pam K, Garrett-Mayer, Elizabeth, Gutierrez, Rodolfo, Ahn, Eugene R, Cannon, Timothy L, Powell, Steven, Krauss, John C, Reynolds, Christopher M, von Mehren, Margaret, Behl, Deepti, Calfa, Carmen J, Duvivier, Herbert L, Kaplan, Henry G, Livingston, Michael B, Sharma, Manish R, Urba, Walter J, Grantham, Gina N, Hinshaw, Dominique C, Gregory, Abigail, Halabi, Susan, Schilsky, Richard L

“…The Targeted Agent and Profiling Utilization Registry Study is a phase II basket study evaluating antitumor activity of commercially available targeted agents…”
Get more information

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse by Zeichner, Simon B., Ambros, Tadeu, Zaravinos, John, Montero, Alberto J., Mahtani, Reshma L., Ahn, Eugene R., Mani, Aruna, Markward, Nathan J., Vogel, Charles L.

“…Background Our original paper, published in 1992, reported a median overall survival after first relapse in breast cancer of 26 months. The current…”
Get full text

Stereotactic radiotherapy for treatment of cavernous sinus meningiomas by Selch, Michael T, Ahn, Eugene, Laskari, Ashkan, Lee, Steve P, Agazaryan, Nhzde, Solberg, Timothy D, Cabatan-Awang, Cynthia, Frighetto, Leonardo, Desalles, Antonio A F

“…To assess the safety and efficacy of stereotactic radiotherapy (SRT) using a linear accelerator equipped with a micromultileaf collimator for cavernous sinus…”
Get more information

Is the Improved Efficacy of Trastuzumab and Lapatinib Combination Worth the Added Toxicity? A Discussion of Current Evidence, Recommendations, and Ethical Issues Regarding Dual HER2-Targeted Therapy by Ahn, Eugene R., Wang, Emilie, Glück, Stefan

“…Following FDA approval of trastuzumab in 1998 and lapatinib in 2007, several clinical studies have addressed the question of whether trastuzumab and lapatinib…”
Get full text

Elevated endothelial microparticle—monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-β1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes by Jimenez, Joaquin J, Jy, Wenche, Mauro, Lucia M, Horstman, Lawrence L, Ahn, Eugene R, Ahn, Yeon S, Minagar, Alireza

“…Monocyte migration through the disrupted cerebral endothelial cell (EC) junctions plays an essential role in formation of multiple sclerosis (MS) demyelinating…”
Get full text